NCT01419964View on ClinicalTrials.gov

Efficacy and Safety of ACH24 in the Treatment of Vitiligo

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2013

Conditions
Vitiligo
Interventions
DRUG

Group 01

ACH24

DRUG

Group 02

Placebo

Trial Locations (1)

80010-030

Irmandade da Santa Casa de Misericórdia de Curitiba, Curitiba

Sponsors
All Listed Sponsors
lead

Ache Laboratorios Farmaceuticos S.A.

INDUSTRY